Kiora Pharmaceuticals (KPRX) Exchange Rate Effect (2014 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Exchange Rate Effect came in at -$16567.0 in Q2 2026, down 112.59% on a YoY basis from $131582.0 in Q2 2025, and down 182.41% quarter-over-quarter from $20103.0 in Q1 2026.
Analysis
Kiora Pharmaceuticals (KPRX) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has reported Exchange Rate Effect for 13 consecutive years, with -$16567.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect fell 112.59% year-over-year to -$16567.0; the trailing twelve-month figure through Jun 2026 stood at $35445.0 (down 72.42% YoY), and the FY2025 full-year result was $173634.0, up 403.39% from the prior year.
- Exchange Rate Effect slipped to -$16567.0 in Q2 2026 per KPRX's latest filing, from $20103.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $131582.0 in Q2 2025 and bottomed at -$136205.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged $3940.1 across 5 years, with a median of $8561.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect slumped 424.71% in 2022, then soared 1785.4% in 2025.
- Over 5 years, Exchange Rate Effect stood at $48961.0 in 2022, then soared by 149.55% to $122184.0 in 2023, then tumbled by 161.78% to -$75485.0 in 2024, then surged by 124.85% to $18755.0 in 2025, then sank by 188.33% to -$16567.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$16567.0, $20103.0, and $18755.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -84,000.00 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Kiora Pharmaceuticals | 15.75 Mn | 15.75 Mn | - | -16,567.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16,567.00 |
| Mar 31, 2026 | 20,103.00 |
| Dec 31, 2025 | 18,755.00 |
| Sep 30, 2025 | 13,154.00 |
| Jun 30, 2025 | 131,582.00 |
| Mar 31, 2025 | 10,143.00 |
| Dec 31, 2024 | -75,485.00 |
| Sep 30, 2024 | 62,299.00 |
| Jun 30, 2024 | 6,979.00 |
| Mar 31, 2024 | -51,024.00 |
| Dec 31, 2023 | 122,184.00 |
| Sep 30, 2023 | -30,174.00 |
| Jun 30, 2023 | -28,845.00 |
| Mar 31, 2023 | -27,145.00 |
| Dec 31, 2022 | 48,961.00 |
| Sep 30, 2022 | -36,468.00 |
| Jun 30, 2022 | -136,205.00 |
| Mar 31, 2022 | 38,675.00 |
| Dec 31, 2021 | -27,132.00 |
| Sep 30, 2021 | -42,536.00 |